Adaptive (ADPT) Reports Strong Q1 2026 Earnings and Raises Full-Year Guidance
Adaptive (NASDAQ: ADPT) reported strong first-quarter earnings for 2026, with MRD revenue growing by 53% year-over-year. The company raised its full-year MRD revenue guidance to $260 million–$270 million due to continued growth in clinical and pharma segments.
Tickers: $ADPT